Compugroup Medical Se Stock Current Liabilities
| CMPVFDelisted Stock | USD 29.89 0.00 0.00% |
CompuGroup Medical SE fundamentals help investors to digest information that contributes to CompuGroup Medical's financial success or failures. It also enables traders to predict the movement of CompuGroup Pink Sheet. The fundamental analysis module provides a way to measure CompuGroup Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CompuGroup Medical pink sheet.
CompuGroup |
CompuGroup Medical SE Company Current Liabilities Analysis
CompuGroup Medical's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, CompuGroup Medical SE has a Current Liabilities of 0.0. This is 100.0% lower than that of the sector and about the same as Current Liabilities (which currently averages 0.0) industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
CompuGroup Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CompuGroup Medical's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CompuGroup Medical could also be used in its relative valuation, which is a method of valuing CompuGroup Medical by comparing valuation metrics of similar companies.CompuGroup Medical is currently under evaluation in current liabilities category among related companies.
CompuGroup Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.89 B | |||
| Shares Outstanding | 52.23 M | |||
| Shares Owned By Insiders | 50.30 % | |||
| Shares Owned By Institutions | 29.69 % | |||
| Price To Earning | 20.14 X | |||
| Price To Book | 2.49 X | |||
| Price To Sales | 1.97 X | |||
| Revenue | 1.03 B | |||
| Gross Profit | 411.46 M | |||
| EBITDA | 213.99 M | |||
| Net Income | 68.97 M | |||
| Cash And Equivalents | 120.07 M | |||
| Cash Per Share | 2.30 X | |||
| Total Debt | 587.08 M | |||
| Debt To Equity | 1.32 % | |||
| Current Ratio | 0.87 X | |||
| Book Value Per Share | 12.87 X | |||
| Cash Flow From Operations | 165.27 M | |||
| Earnings Per Share | 1.49 X | |||
| Number Of Employees | 8.83 K | |||
| Beta | 1.07 | |||
| Market Capitalization | 2.39 B | |||
| Total Asset | 1.79 B | |||
| Z Score | 2.4 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 1.79 B |
About CompuGroup Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CompuGroup Medical SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CompuGroup Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CompuGroup Medical SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| OEPIX | Oil Equipment Services | |
| MMM | 3M Company | |
| SLV | iShares Silver Trust | |
| AZPN | Aspen Technology | |
| ORCL | Oracle |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CompuGroup Medical SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in CompuGroup Pink Sheet
If you are still planning to invest in CompuGroup Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CompuGroup Medical's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |